This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03553/identifier/chebi/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03553/identifier/kegg-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB03553/identifier/pdb/
n4http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB03553/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03553/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n15http://linked.opendata.cz/resource/drugbank/drug/DB03553/identifier/drugbank/
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03553
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB03553 n7:DB03553
dcterms:title
Glutaric Acid
adms:identifier
n10:743 n11:46506371 n12:C00489 n13:GUA n14:17859 n15:DB03553
n5:synthesisReference
Guiseppe Gigliotti, Jean-Michel Roul, "Process for the preparation of 3-methyl-3-hydroxy-glutaric acid." U.S. Patent US4467108, issued June, 1980.
n5:IUPAC-Name
n6:271B52ED-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B52F3-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B52F2-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B52EF-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B52F0-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B52F1-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B52EB-363D-11E5-9242-09173F13E4C5 n6:271B5302-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B52EC-363D-11E5-9242-09173F13E4C5 n6:271B52E9-363D-11E5-9242-09173F13E4C5 n6:271B5305-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B52EA-363D-11E5-9242-09173F13E4C5 n6:271B5306-363D-11E5-9242-09173F13E4C5
n5:pKa
n6:271B5307-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B52F9-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B52FA-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B52F4-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B52F5-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B52F7-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B52F6-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B52F8-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
110-94-1
n5:Bioavailability
n6:271B52FE-363D-11E5-9242-09173F13E4C5
n5:Boiling-Point
n6:271B5304-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5300-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5301-363D-11E5-9242-09173F13E4C5
n5:Melting-Point
n6:271B5303-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B52FD-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B52FC-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B52FF-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B52EE-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B52FB-363D-11E5-9242-09173F13E4C5